Louis Edward Tamayo

Chief Financial Officer, Lexeo Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Aug 18, 2026

Companies

Lexeo Therapeutics, Inc.Chief Financial Officer −$0.0M

Trades

LXEO Sold 4,117 shares at $4.91 $0.0M Aug 18

LXEO Sold 4,641 shares at $4.49 $0.0M Jul 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.